Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum

Aberrant epigenetic modifications are an early event in carcinogenesis, with the epigenetic landscape continuing to change during tumor progression and metastasis—these observations suggest that specific epigenetic modifications could be used as diagnostic and prognostic biomarkers for many cancer t...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Margaret L., Marcato, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923356/
https://www.ncbi.nlm.nih.gov/pubmed/29614786
http://dx.doi.org/10.3390/cancers10040101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923356/
https://www.ncbi.nlm.nih.gov/pubmed/29614786
http://dx.doi.org/10.3390/cancers10040101

Ejemplares similares